MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceutical Drug Discovery & Development (Miscellaneous)
OMass Therapeutics
Attachments
www.omass.com
Parents
*Architects: BioPharmaceutical Drug Discovery & Development (Miscellaneous)
*Industry: United Kingdom - UK (England, Scotland, Wales, Northern Ireland)
Venture Capital: Series B
Children
2022: GV, Sanofi drive British biotech OMass to $100M series B, fueling work on undruggable targets
CEO Ros Deegan, OMass (2022)
Oxford, England, United Kingdom
Jumps
University of Oxford